"If you're correct, there's is no possibility of FDA approval for Pennsaid............"
I don't think that was the message in Bluejay's post. FDA approval, some wonderful use for WF10, Penecure, may all come about. Its just that right now, with all the uncertainty about what the new management may uncover, there is just no compelling reason to slap one's money down on this stock. An investor can always make money somewhere else and come back to this puppy when there is a clearer picture.
Regarding FDA approval. Its like waiting for Godot. Is there a good reason to park your money in this stock, waiting for the imminant approval, or come back after the approval? Just how much of gain will the investor give up?
Regarding WF10. The failure of the HIV/AIDS trial has to be a concern for the investor. With all the action of late surronding REK's ouster, there has been little discussion of this event. Hopefully, the new management group will shed some new and truthful light on what happened. If DMX is to become a research organization that wants to exploit WF10, they will have to explain how a drug that did so well in short term trials, bombed so badly in a longer trial. I know, I know..intent to treat.
Regarding Penecure. No doubt, its potential looks great. It will however take some time for trial results to become available. A whole lot of aqua will flow under the bridge before that happens. (no pun intended, I think).
So I too share Dave's sentiment. So why did I buy more shares last week? This stock has got me f**ked up. |
